Carlo Trani1,2, Giulio Russo1,2, Cristina Aurigemma1,2, Francesco Burzotta1,2. 1. Polo Cardiovascolare, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go Gemelli 8, Roma, Italy. 2. Università Cattolica del Sacro Cuore, Largo Gemelli, Roma, Italy.
Abstract
BACKGROUND: Highly calcific stenosis located in common femoral artery (CFA) represents a difficult target for endovascular treatment due to the possible need for stent implantation in that area. CASE SUMMARY: A 63-year-old man with history of coronary artery disease and previous multiple percutaneous transluminal angioplasties for peripheral artery disease (PAD) was admitted for recent onset left lower limb pain at rest with severe activity restriction (Leriche-Fontaine Class III and Rutherford Class III-IV). The angio-computed tomography scan showed a highly calcific stenosis of left CFA. The patient underwent lithoplasty balloon angioplasty followed by drug-eluting balloon inflation with excellent angiographic result and complete blood flow restoration. No procedural complications occurred. DISCUSSION: Highly calcified stenosis in PAD represents a huge challenge for endovascular treatment as not all lower extremity arteries are suitable for stenting because of compressive and torsional forces associated with stent fracture and restenosis. Lithoplasty is a new technology allowing effective blood flow restoration while minimizing vessel injury.
BACKGROUND: Highly calcific stenosis located in common femoral artery (CFA) represents a difficult target for endovascular treatment due to the possible need for stent implantation in that area. CASE SUMMARY: A 63-year-old man with history of coronary artery disease and previous multiple percutaneous transluminal angioplasties for peripheral artery disease (PAD) was admitted for recent onset left lower limb pain at rest with severe activity restriction (Leriche-Fontaine Class III and Rutherford Class III-IV). The angio-computed tomography scan showed a highly calcific stenosis of left CFA. The patient underwent lithoplasty balloon angioplasty followed by drug-eluting balloon inflation with excellent angiographic result and complete blood flow restoration. No procedural complications occurred. DISCUSSION: Highly calcified stenosis in PAD represents a huge challenge for endovascular treatment as not all lower extremity arteries are suitable for stenting because of compressive and torsional forces associated with stent fracture and restenosis. Lithoplasty is a new technology allowing effective blood flow restoration while minimizing vessel injury.
Highly calcific stenosis located in common femoral artery (CFA) represents a huge challenge for endovascular treatment.Stent positioning in CFA may be limited by the compressive or torsional forces leading to stent fracture and/or restenosis.Lithoplasty balloon angioplasty is an effective treatment for calcific vessels and may represent a safe tool also for CFA.
Introduction
Endovascular approach has become the first choice treatment for lower extremity artery disease (LEAD), as recommended by the European Society of Cardiology guidelines on the diagnosis and treatment of peripheral artery disease (PAD). However, common femoral artery (CFA) still represents an almost forbidden target for endovascular treatment due to the reluctance to implant a stent in that area if needed. Moreover, highly calcified lesions represent a challenging subset as technical success and patency rates are poor, affecting both short- and long-term outcome. Circumferential distribution of calcium is the most negative influencing factor and increases the occurrence of flow-limiting dissections and acute vessel recoil after percutaneous transluminal angioplasty (PTA). Furthermore, stenting itself may be impaired due to subexpansion, malapposition, and fractures.Directional atherectomy followed by drug-eluting balloon (DEB) inflation showed positive results in small studies,, although data are still controversial., Alternatively, scoring balloon has been demonstrated to be safe and effective for both femoropopliteal and infrapopliteal lesions, but data are still limited.,Recently, a new device, the Shockwave Medical Peripheral Lithoplasty System, has demonstrated its safety and efficacy in the treatment of calcified, stenotic infrainguinal peripheral arteries. It integrates two functions:the intermittent pulsatile mechanical energy of lithotripsy disrupt the calcium; andthe integrated balloon dilates the lesion restoring the blood flow.It has been tested in a two-phase, single arm, prospective, multicentre study, DISRUPT PAD I and II where high rates of procedural success, patency, and freedom from target lesion revascularization at 30 days and at 6 months were reported. As regards safety outcomes no vascular complications occurred and no stents were implanted. Distal embolic filters were used in six patients and thrombus was found in only one filter. Consequently, it may play an important role in severely calcific LEAD management.
Case presentation
A 63-year-old man with history of coronary artery disease treated by coronary artery bypass graft was admitted for recent onset left lower limb pain at rest with severe activity restriction (Leriche-Fontaine Class III and Rutherford Class III–IV). He had already undergone PTA with stent implantation on the left superficial femoral artery several years before.An angio-computed tomography was performed showing highly calcific stenotic left CFA, (Figure A and B). Despite the high calcium burden no severe calcific stenosis was found on the right side. After in-depth discussion with the patient and upon his strong preference, a decision to attempt endovascular treatment was taken. Patient gave inform consent.
Figure 1
(A and B) Computed tomography scan image before treatment.
(A and B) Computed tomography scan image before treatment.
Access site
Shockwave balloons from 3.5 to 6 mm are 6-Fr introducer sheath-compatible with 110 cm length so a right femoral approach with crossover technique was selected.In order to increase precision, ultrasonographic guidance was adopted for the right common femoral puncture. A 6-Fr sheath was placed and left common iliac artery access was obtained through a Judkins right guiding catheter. A subtraction angiography of the left iliac-femoral axis was then performed confirming highly calcific stenosis of the CFA (Figure ).
Figure 2
Common femoral artery angiogram.
Common femoral artery angiogram.
Angioplasty technique
Severely calcific stenosis was crossed with 300 cm Choice PT Extra-Support guidewire (Boston Scientific). Lithotripsy catheter (Shockwave Medical Inc.) was advanced to the lesion site, so the manufacturer’s instructions were followed:lithoplasty balloon (6 × 60 mm) inflation to 4 atm (Figure ).
Figure 3
Lithoplasty balloon inflation in common femoral artery.
Shockwave treatment (30 pulses).Lithoplasty balloon deflation in order to re-establish blood flow (30 s).Further lithoplasty balloon inflation to 6 atm (30 s).The same sequence was repeated for six times for a total of 180 pulses in the same segment.Lithoplasty balloon inflation in common femoral artery.After the entire shockwave treatment was completed an angiogram was performed in order to assess post-intervention result (Figure ). After calcifications disruption, the lesion was finally dilated with a 7 × 60 mm DEB and the final arteriogram showed a good angiographic final result with completely restored flow and no residual vascular calcium.
Figure 4
Final angiography.
Final angiography.The patient was discharged the day after the procedure and after 9-month follow-up, no symptoms/activity restriction were reported.
Discussion
Although the true prevalence of vascular calcification in symptomatic PAD patients may vary a lot, we know that it represents a significant challenge for current endovascular device strategies. Indeed, it increases the procedure-related adverse events from early elastic recoil to dissections, perforations, and embolization, which, in some cases, lead to bailout stenting. However, not all lower extremity arteries are suitable for stenting as subject to compressive or torsional forces and consequently associated with stent fracture and restenosis.In this perspective, the use of innovative techniques may help in the treatment of severely calcific lesions.Lithotripsy is a well-established treatment adopted for calcified renal calculi, in which calcifications are fragmented by high-power acoustic shockwaves. Lithoplasty is a new technology based on lithotripsy where the circumferential pulsatile energy disrupting the calcified plaque is combined with the balloon inflation force. It is effective to restore blood flow into the highly calcified stenotic artery, minimizing vessel injury.The case we described is the first case of lithoplasty applied to the CFA as the previous studies (PAD I and II) were focused on superficial femoral artery and popliteal lesions and some reports exist on iliac treatment. Although a recent paper showed positive results for stenting, CFA is usually considered not suitable for stenting consequently PTA in this segment needs to be very careful. In a retrospective analysis, Guo et al. have recently demonstrated that atherectomy might be better than angioplasty for CFA atherosclerotic obstructive lesions, especially in bifurcations. However, this technique might be limited by the high rates of dissection and consequent need for stenting. Angioplasty and provisional stenting were also compared in 96 patients undergoing isolated percutaneous revascularization of CFA. In more than one-third of patients undergoing angioplasty, stent placement became necessary, with a restenosis 14%.In our case, lithoplasty balloon was highly effective as shown by the pre- and post-procedural angiograms (Figures and ), and was safe as no early/late vascular complication occurred. Although larger studies are needed to confirm our result, peripheral lithoplasty seems a promising system for the treatment of highly calcified lesions not only in the superficial femoral artery and popliteal segments but also in CFA.
Lead author biography
Professor Carlo Trani is the Head of Cath Lab at Catholic University of the Sacred Heart in Rome.
Supplementary material
Supplementary material is available at European Heart Journal - Case Reports online.Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data.Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance.Conflict of interest: F.B. discloses to have been involved in advisory board meetings or having received speaker’s fees from Medtronic, St Jude Medical, Abiomed, and Biotronic. C.T. discloses to have been involved in advisory board meetings or having received speaker’s fees from St Jude Medical, Abiomed, and Biotronic. C.A. has been involved in advisory board activities by Biotronic. G.R. has no conflict of interest to declare.Click here for additional data file.
Past cardiovascular history
Left superficial femoral artery percutaneous transluminal angioplasties + stenting and coronary artery bypass grafting
One month prior to admission
Left lower limb pain at rest with severe activity restriction
In-hospital management
Lithoplasty balloon angioplasty in common femoral artery
Six-month follow-up
Patient still asymptomatic for limb pain and no activity restriction occurrence
Authors: Marianne Brodmann; Martin Werner; Todd J Brinton; Uday Illindala; Alexandra Lansky; Michael R Jaff; Andrew Holden Journal: J Am Coll Cardiol Date: 2017-08-15 Impact factor: 24.094
Authors: Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais Journal: Eur Heart J Date: 2018-03-01 Impact factor: 29.983
Authors: Satjit Adlakha; Mujeeb Sheikh; Jason Wu; Mark W Burket; Utpal Pandya; William Colyer; Ehab Eltahawy; Christopher J Cooper Journal: J Interv Cardiol Date: 2010-08 Impact factor: 2.279
Authors: Robert F Bonvini; Aljoscha Rastan; Sebastian Sixt; Ulrich Beschorner; Elias Noory; Thomas Schwarz; Marco Roffi; Pierre-André Dorsaz; Uwe Schwarzwälder; Karlheinz Bürgelin; Roland Macharzina; Thomas Zeller Journal: J Vasc Interv Radiol Date: 2013-01-28 Impact factor: 3.464
Authors: Sebastian Sixt; Oscar Gerardo Carpio Cancino; András Treszl; Ulrich Beschorner; Roland Macharzina; Aljoscha Rastan; Hans Krankenberg; Franz-Josef Neumann; Thomas Zeller Journal: J Vasc Surg Date: 2013-06-04 Impact factor: 4.268
Authors: Thomas Zeller; Ralf Langhoff; Krishna J Rocha-Singh; Michael R Jaff; Erwin Blessing; Beatrice Amann-Vesti; Marek Krzanowski; Patrick Peeters; Dierk Scheinert; Giovanni Torsello; Sebastian Sixt; Gunnar Tepe Journal: Circ Cardiovasc Interv Date: 2017-09 Impact factor: 6.546